Impact of COVID-19 pandemic on SLE: beyond the risk of infection

Lupus Sci Med. 2020 May;7(1):e000408. doi: 10.1136/lupus-2020-000408.

Authors

Alice Horisberger¹, Laura Moi¹, Camillo Ribi¹, Denis Comte²

Affiliations

¹ Service of Immunology and Allergy, Departement de medecine, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.
² Service of Immunology and Allergy, Departement de medecine, Centre hospitalier universitaire vaudois, Lausanne, Switzerland [email protected].

No abstract available

Keywords: antirheumatic agents; interferon type I; lupus erythematosus, systemic.

Publication types

Letter

MeSH terms

Betacoronavirus / isolation & purification
COVID-19
Coronavirus Infections / epidemiology
Coronavirus Infections / prevention & control*
Coronavirus Infections / virology
Humans
Lupus Erythematosus, Systemic / diagnosis*
Lupus Erythematosus, Systemic / drug therapy*
Pandemics / prevention & control*
Pneumonia, Viral / epidemiology
Pneumonia, Viral / prevention & control*
Pneumonia, Viral / virology
SARS-CoV-2